Blood platelets contain tumor-derived RNA biomarkers

Jonas Nilsson, Leonora Balaj, Esther Hulleman, Sjoerd van Rijn, D. Michiel Pegtel, Maudy Walraven, Anders Widmark, Winald R. Gerritsen, Henk M. Verheul, William P. Vandertop, David P. Noske, Johan Skog, Thomas Wurdinger

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

Samenvatting

Diagnostic platforms providing biomarkers that are highly predictive for diagnosing, monitoring, and stratifying cancer patients are key instruments in the development of personalized medicine. We demonstrate that tumor cells transfer (mutant) RNA into blood platelets in vitro and in vivo, and show that blood platelets isolated from glioma and prostate cancer patients contain the cancer-associated RNA biomarkers EGFRvIII and PCA3, respectively. In addition, gene-expression profiling revealed a distinct RNA signature in platelets from glioma patients compared with normal control subjects. Because platelets are easily accessible and isolated, they may form an attractive platform for the companion diagnostics of cancer.
Originele taal-2Engels
Pagina's (van-tot)3680-3683
TijdschriftBlood
Volume118
Nummer van het tijdschrift3
DOI's
StatusGepubliceerd - 29 sep. 2011
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Blood platelets contain tumor-derived RNA biomarkers'. Samen vormen ze een unieke vingerafdruk.

Citeer dit